MedPath

Comparison clinical efficacy of nebulized LMWH plus salbotamol in contrast with nebulized salbotamol alone in management of acute asthma attack

Phase 3
Conditions
Asthma
Acute Asthma Exacerbation.
Registration Number
IRCT2015092215446N4
Lead Sponsor
Ahvaz Jundishapur University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
54
Inclusion Criteria

1- Age above 18 years old. 2- Documented Asthmatic Patients with Spiropmetry.

Exclusion Criteria

1- Not response to therapy. 2- Use of epinephrine or MgSO4 or IPPV during treatment. 3- Patient refuse from continue of treament. 4- Lung diseases like ILD. 5- Cigarrete smoking.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Forced Expiratory Volume in First Second (FEV1). Timepoint: Before intervention, 30 minutes after intervention, 60 minutes after intervention, 90 minutes after intervention. Method of measurement: Milliliter with use of Peak Flow Meter.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath